Vignan Institute of Pharmaceutical Sciences Nalgonda: Fees, Admission 2026, Courses, Cutoff, Ranking, Placement

Nalgonda, TelanganaEstd 1999 JNTUK, Kakinada

Courses Offered By Vignan Institute of Pharmaceutical Sciences Nalgonda 2026

Clear
2 years
(Full Time)
Application Date1 Aug - 18 Aug 2026
CoursesPharmaceutics & 2 more
2 Views(Last year)
Fees Structure
4 years
(Full Time)4.8(1 review)
Application Date19 June - 31 Jul 2026
Fees Structure
6 years
(Full Time)
Application Date1 Nov - 04 Nov 2026
Fees Structure

Do you think the fees are wrong ?  Report Here

Vignan Institute of Pharmaceutical Sciences Nalgonda Upcoming Important Dates 2026

Important Events

EventsDates
Admission Timeline [Ph.D] (Pharmacy)
Tentative
Nov 01, 2026 - Nov 04, 2026

Important Events

EventsDates
Admission Timeline [Ph.D] (Pharmacy)
Tentative
Nov 01, 2026 - Nov 04, 2026

Expired Events

EventsDates
Admission Timeline [M.Pharm]
Aug 01, 2026 - Aug 18, 2026
Download Allotment Order, Self Reporting & Branch Reporting - Internal Sliding TGEAPCET 2026 [B.Pharm]
Aug 16, 2026 - Aug 17, 2026
Spot Admission Guidelines Publication TGEAPCET 2026 [B.Pharm]
Aug 16, 2026

Do you think the Dates are wrong ?  Report Here

Course Finder

Search from 20K+ Courses and 35+ Streams

Clear

Vignan Institute of Pharmaceutical Sciences Nalgonda College Details

Basic Information About the Colleges

Vignan Hills, Near Ramoji filmcity, Deshmukhi, Pochampally
Nalgonda - 530049
Telangana, India
Get SMS Contact:  9866399799
Get Call Details:  9866399799
Copy Direction

Comments


Found 1 Comment

M
manisha
Apr 11, 2025 13:49
WHAT IS THE FEES STRUCTURE FOR M.PHARM PHARMACOLOGY 2025-2027 BATCH
S
Sweta Kumari
Apr 14, 2025 23:05

The TS PGECET 2025 exam schedule has been released for admission to ME/M.Tech, M.Pharm, M.Arch & PharmD (PB) programs. Online registrations will be open from March 17 to May 19, 2025, on the official website, tgche.ac.in. JNTUH will conduct the exam from June 16 to 19, 2025. The total fee for the MPharma course is INR 2,20,000.


- No More Comments -